Your browser doesn't support javascript.
loading
Combined loss of TFF3 and PTEN is associated with lethal outcome and overall survival in men with prostate cancer.
Abou-Ouf, Hatem; Ghosh, Sunita; Box, Adrian; Palanisamy, Nallasivam; Bismar, Tarek A.
Afiliação
  • Abou-Ouf H; Department of Pathology and Laboratory Medicine, University of Calgary Cumming School of Medicine and Calgary Laboratory Services, Calgary, AB, Canada.
  • Ghosh S; Department of Medical Oncology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
  • Box A; Department of Pathology and Laboratory Medicine, University of Calgary Cumming School of Medicine and Calgary Laboratory Services, Calgary, AB, Canada.
  • Palanisamy N; Department of Urology, Vattikuti Urology Institute, Henry Ford Health System Detroit, Detroit, MI, USA.
  • Bismar TA; Department of Pathology and Laboratory Medicine, University of Calgary Cumming School of Medicine and Calgary Laboratory Services, Calgary, AB, Canada. tabismar@ucalgary.ca.
J Cancer Res Clin Oncol ; 145(7): 1751-1759, 2019 Jul.
Article em En | MEDLINE | ID: mdl-31129769
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / PTEN Fosfo-Hidrolase / Fator Trefoil-3 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / PTEN Fosfo-Hidrolase / Fator Trefoil-3 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá